Safety of Abatacept Administered Intravenously in Treatment of Rheumatoid Arthritis: Integrated Analyses of Up to 8 Years of Treatment From the Abatacept Clinical Trial Program

Journal of Rheumatology - Canada

doi 10.3899/jrheum.120906